Skip to main content
Explore URMC


Patrick M. Reagan, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Fax: (585) 273-1042

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting



I chose this specialty because I had an interest in lymphoid malignancies throughout my training, and I am excited to be part of a field that is moving rapidly toward targeted treatments. This translates into more options that are effective and well-tolerated for patients.

In addition, I strongly believe in the enrollment of patients in well-designed clinical trials in both the upfront and relapsed settings. Clinical trials enable our lymphoma program to remain on the cutting edge of clinical care. My areas of expertise include the treatment of older patients with lymphoid malignancies, as well as clinical trial development in this population.

Conditions I Treat:

- Non-Hodgkin lymphoma
- Hodgkin lymphoma
- Chronic lymphocytic leukemia



  • Hematology - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine


BS | St. Lawrence University

MD | SUNY Upstate Medical University

Post-doctoral Training & Residency

07/01/2013 - 06/30/2015
Fellowship in Hematology/Oncology at University of Rochester Medical Center - GME Office

07/01/2012 - 07/01/2013
Residency in Internal Medicine at University of Virginia Children's Hospital

07/01/2010 - 07/01/2012
Residency in Internal Medicine at University of Virginia Children's Hospital

07/01/2009 - 7/1/2010
Internship in Internal Medicine at University of Virginia Children's Hospital

VIEW ALL expand_more


Lymphoma Research Foundation Clinical Research Mentoring Program

American Society of Hematology Clinical Research Training Institute

John and Carol Bennett Travel Fellowship Award
Sponsor: John and Carol Bennett
Location: Wilmot Cancer Institute

Alpha Omega Alpha, Upstate Medical University
Sponsor: Upstate Medical University

Phi Beta Kappa, St. Lawrence University
Sponsor: St. Lawrence University

Academic All American, Football, St. Lawrence University
Sponsor: St. Lawrence University

Beta Beta Beta, Biological Honor Society, St. Lawrence University
Sponsor: St. Lawrence University

VIEW ALL expand_more


Journal Articles

"Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial." The Lancet. Oncology.. 2018 Nov 30; Epub 2018 Nov 30.

Williams AM, Baran AM, Casulo C, Reagan P, Friedberg JW, Helber M, Moore J, Baloga E, Zent CS, Barr PM. "Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience." Clinical lymphoma, myeloma & leukemia.. 2018 Oct 13; Epub 2018 Oct 13.

Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, Braunschweig I, Oluwole OO, Siddiqi T, Lin Y, Timmerman JM, Stiff PJ, Friedberg JW, Flinn IW, Goy A, Hill BT, Smith MR, Deol A, Farooq U, McSweeney P, Munoz J, Avivi I, Castro JE, Westin JR, Chavez JC, Ghobadi A, Komanduri KV, Levy R, Jacobsen ED, Witzig TE, Reagan P, Bot A, Rossi J, Navale L, Jiang Y, Aycock J, Elias M, Chang D, Wiezorek J, Go WY. "Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma." The New England journal of medicine.. 2017 Dec 28; 377(26):2531-2544. Epub 2017 Dec 10.